Ticker > Company >

Sai Parenteral''s share price

Sai Parenteral''s Ltd.

NSE: SAIPARENT BSE: 544742 SECTOR: Pharmaceuticals & Drugs  514   0   0

429.00
+5.85 (1.38%)
BSE: Today, 12:35 PM

Price Summary

Today's High

₹ 435.75

Today's Low

₹ 417.35

52 Week High

₹ 442.55

52 Week Low

₹ 400

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1895.29 Cr.

Enterprise Value

1961.93 Cr.

No. of Shares

4.42 Cr.

P/E

413.41

P/B

0

Face Value

₹ 5

Div. Yield

0 %

Book Value (TTM)

₹  0

CASH

1.91 Cr.

DEBT

68.55 Cr.

Promoter Holding

51.16 %

EPS (TTM)

₹  1.04

Sales Growth

0%

ROE

14.56 %

ROCE

12.97%

Profit Growth

0 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 YearNA
3 YearNA
5 YearNA

ROE%

1 Year14.56%

ROCE %

1 Year12.97%

Debt/Equity

2.1776

Price to Cash Flow

-90.99

Interest Cover Ratio

2.267

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 51.16 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 51.16%.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of 0% over the past 3 years
  • Company has high debtor days of 230.8042.
  • Company has negative cash flow from operations of -20.8287.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 103.6983.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023
Net Sales 96.8
Total Expenditure 78.24
Operating Profit 18.56
Other Income 0.21
Interest 5.72
Depreciation 5.79
Exceptional Items 0
Profit Before Tax 7.25
Tax 2.67
Net Profit 4.6
Adjusted EPS (Rs.) 3.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023
Equity and Liabilities
Share Capital 7.15
Total Reserves 24.33
Borrowings 25.64
Other N/C liabilities 0.22
Current liabilities 76.63
Total Liabilities 133.97
Assets
Net Block 44.47
Capital WIP 1.6
Intangible WIP 0
Investments 0
Loans & Advances 2.18
Other N/C Assets 0
Current Assets 85.72
Total Assets 133.97
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023
Profit from operations 7.25
Adjustment 11.45
Changes in Assets & Liabilities -36.83
Tax Paid -2.7
Operating Cash Flow -20.83
Investing Cash Flow -17.26
Financing Cash Flow 30.23
Net Cash Flow -7.85

Corporate Actions

Investors Details

PARTICULARS Mar 2026%
promoters 51.16
anil kumar karusala 10.32
aruna karusala 7.40
kunal kakumanu 4.53
vijitha gorrepati 28.91
PARTICULARS Mar 2026%
investors 48.84
agilis partners llp 2.06
aig direct llc 2.12
astorne capital vcc - arv... 1.15
bhaskara rao bollineni 2.90
doppalapudi pooja lakshmi... 1.33
kotak life sciences fund ... 1.73
kotak mahindra life insur... 2.89
nanda govind bhattad 1.66
quant mutual fund - quant... 3.81
reina r jaisinghani 1.59
samarsh capital-samarsh c... 3.45
sapna sameer shah 1.53
yashwant amratlal thakkar... 1.73

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Sai Parenteral''s Stock Price Analysis and Quick Research Report. Is Sai Parenteral''s an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sai Parenteral''s. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sai Parenteral''s has a PE ratio of 409.752336898911 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sai Parenteral''s has ROA of 3.4221% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sai Parenteral''s has a Current ratio of 1.1186.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sai Parenteral''s has a ROE of 14.564%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sai Parenteral''s has a Debt to Equity ratio of 2.1776 which means that the company has high proportion of debt in its capital.

  • Sales growth: Sai Parenteral''s has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sai Parenteral''s for the current financial year is 19.1750692177363%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sai Parenteral''s is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sai Parenteral''s is Rs 1.0377. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sai Parenteral''s in Ticker for free. Also, one can get the intrinsic value of Sai Parenteral''s by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sai Parenteral''s FAQs

Q1. What is Sai Parenteral''s share price today?
Ans: The current share price of Sai Parenteral''s is Rs 425.2.

Q2. What is the market capitalisation of Sai Parenteral''s?
Ans: Sai Parenteral''s has a market capitalisation of Rs 1878.50090212 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sai Parenteral''s?
Ans: The PE ratio of Sai Parenteral''s is 409.752336898911 and the P/B ratio of Sai Parenteral''s is 0, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sai Parenteral''s share?
Ans: The 52-week high share price of Sai Parenteral''s is Rs 443.9, and the 52-week low share price of Sai Parenteral''s is Rs 400.

Q5. Does Sai Parenteral''s pay dividends?
Ans: Currently, Sai Parenteral''s does not pay dividends. Dividend yield of Sai Parenteral''s is around 0%.

Q6. What are the face value and book value of Sai Parenteral''s shares?
Ans: The face value of Sai Parenteral''s shares is Rs 5, while the book value per share of Sai Parenteral''s is around Rs 0. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sai Parenteral''s?
Ans: Sai Parenteral''s has a total debt of Rs 68.5469 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sai Parenteral''s?
Ans: The ROE of Sai Parenteral''s is 14.564% and ROCE of Sai Parenteral''s is 12.9741%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sai Parenteral''s a good buy for the long term?
Ans: The Sai Parenteral''s long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sai Parenteral''s undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sai Parenteral''s appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sai Parenteral''s’s financials?
Ans: You can review Sai Parenteral''s’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Sai Parenteral''s Share Price News

Latest updates on Sai Parenteral''s share price and stock news.

Last Updated on:
Brief about Sai Parenteral''s
X